PEOPLE - ImmunoDiagnostic Systems (UK) makes appointments:
This article was originally published in Clinica
Executive Summary
ImmunoDiagnostic Systems (Boldon, UK), a developer, manufacturer and marketer of esoteric immunoassay kits, has made four senior appointments. Gerry Allen, who has over 27 years of experience in the IVD industry, has been appointed to the executive board as technical director. Michael Chard, who most recently served at Bio-Diagnostics, has been appointed as head of assay development. David Laurie, who has served as head of R&D at the company since 1996, has been promoted to head of core technology. David Evans, who serves on a number of biotech company boards, has been appointed as chairman and non-executive director.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.